Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model.
about
Animal Models of Osteoarthritis: Comparisons and Key ConsiderationsGene therapy approaches to regenerating the musculoskeletal systemBiocompatibility and in vivo osteogenic capability of novel bone tissue engineering scaffold A-W-MGC/CS.Hydroxyapatite and demineralized calf fetal growth plate effects on bone healing in rabbit model.Ordinary and Activated Bone Grafts: Applied Classification and the Main Features.Accelerated Chondrogenic Differentiation of Human Perivascular Stem Cells with NELL-1Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model.Gene therapy approaches to regenerating bone.Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.Realizing the potential of gene-based molecular therapies in bone repair.Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissuesUse of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches.Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations.Gene therapy for chondral and osteochondral regeneration: is the future now?BMP-2 gene activated muscle tissue fragments for osteochondral defect regeneration in the rabbit knee.Use of contrast media in computed tomography and magnetic resonance imaging in horses: Techniques, adverse events and opportunities.Feasibility for mapping cartilage t1 relaxation times in the distal metacarpus3/metatarsus3 of thoroughbred racehorses using delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC): normal cadaver study.SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells.Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo.Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo.Decorin-PEI nanoconstruct attenuates equine corneal fibroblast differentiation.Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects.Current perspectives on biological approaches for osteoarthritis.Cranial bone regeneration via BMP-2 encoding mesenchymal stem cells.Scaffolds for Growth Factor Delivery as Applied to Bone Tissue Engineering
P2860
Q26998936-7CDD4F3B-F821-4E4B-94F5-850E9EE236A6Q28083399-E3AD70A7-FD70-46D4-8688-A77AC2DE6E27Q34989313-DC80E5C2-ABDF-4802-ACCC-5DC0D8AF5F11Q35638018-1B282D29-3167-476D-8BCD-D45862D95E52Q36327911-C0CE34CD-A45C-476D-A1D7-ECD6C206ABA7Q36654644-7DFA3E97-EE38-46BA-A2F6-BFFDD3CFD0ACQ37253278-654EC244-A855-4CC7-B117-8C3E6FFAD4D7Q37994898-24E5D368-2F04-4302-9830-0389D792DF86Q38068244-CF60968F-68DC-4375-84D3-C9C2329379F9Q38095878-19097C64-BFC9-4467-87CF-8BBFA2BF7FF3Q38231254-F622E73B-0191-4E74-84B6-470A4E1C1D79Q38245620-386184B4-8B9F-4ABC-92A8-AD07FA3A92C2Q38256807-BF1F8635-8DCE-43C1-8815-049B59F4152AQ38634077-AFC19E9E-E3F1-4B51-8B8A-BDD5A0D10596Q38660922-7E7F4A09-801A-44BC-9BB4-D13BD3019944Q38838147-9C3C9B3D-E1B8-44F7-90ED-C6B06D36A3E3Q39441050-2BD0FE2F-553C-403A-ACCA-F33552C138F4Q42028391-45044608-32FB-4D73-A5AF-A4B013D20B6BQ42208602-B4731024-9922-4964-A05D-0105AC373118Q43841888-1451EF82-1D40-4A5C-A6BC-DC650F0B783AQ44905144-283256FA-E650-4BFC-9DAB-7093EC31C82AQ45880250-CC6F8F18-B039-4696-B86D-934B7887EE2EQ47229491-4FEDD409-5539-47F0-AD0A-173D1F7AEFCEQ51426333-9E1F44EE-3D6F-42CD-87E4-4610EE399EE9Q58689174-8A4B726D-F98D-44E2-8F46-965EF864F674
P2860
Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Direct delayed human adenovira ...... in a pony osteochondral model.
@en
Direct delayed human adenovira ...... in a pony osteochondral model.
@nl
type
label
Direct delayed human adenovira ...... in a pony osteochondral model.
@en
Direct delayed human adenovira ...... in a pony osteochondral model.
@nl
prefLabel
Direct delayed human adenovira ...... in a pony osteochondral model.
@en
Direct delayed human adenovira ...... in a pony osteochondral model.
@nl
P2093
P921
P1476
Direct delayed human adenovira ...... in a pony osteochondral model.
@en
P2093
A L Bertone
D C Flanigan
M I Menendez
S E Weisbrode
P304
P356
10.1016/J.JOCA.2011.05.007
P577
2011-06-02T00:00:00Z